Medtronic plc (MDT)
What changed in recent filings
- Institutions — 4 new · 3 added13F · as of end of 2026 Q2
- Risk factors — 4 added · 4 removed · new: We are subject to litigation, claims, inves… +310-K Apr 25, 2025 → Apr 24, 2026 · filed 2 months ago
What changed in recent SEC filings — factual, not a buy/sell recommendation.
Institutions holding Medtronic plc
How many of the institutions we track reported holding this stock, quarter by quarter.
2019 Q1: 4 → 2026 Q2: 8 institutions
Counts the 52 institutions we track that reported holding this stock — their full reported holdings, not just the largest positions. Not the total number of institutional holders in the US. Figures are as of quarter-end and disclosed up to 45 days later. Descriptive only — not investment advice.
Which institutions hold Medtronic plc
Institutions we track that reported holding this stock in their most recent 13F.
- Dodge & Cox0.32% of portfolio · held as of 2019 Q1 or earlier
- Baillie Gifford & Co0.03% of portfolio · since 2020 Q4
- Bridgewater Associates0.15% of portfolio · since 2024 Q1
- Tudor Investment Corp0.01% of portfolio · since 2026 Q1
- Pzena Investment Management0.72% of portfolio · held as of 2026 Q2 or earlier
- Capital World Investors0.08% of portfolio · held as of 2026 Q2 or earlier
- National Pension Service (Korea)0.16% of portfolio · held as of 2026 Q2 or earlier
- Caisse de depot (Quebec)0.02% of portfolio · held as of 2026 Q2 or earlier
Based on 13F filings — quarter-end holdings, disclosed up to 45 days later. Holding a stock is a fact we report, not a recommendation to buy or sell.
Company overview
Medtronic. The world's largest medical-device company. It holds a broad product range in cardiac, neuro, spine, and diabetes fields.
What is the Biotech & Health sector?
Pharma, biotech, and medical devices. Driven by trial-result events.
Medtronic plc is classified under the Biotech & Health sector. See peers below.
ETFs holding Medtronic plc
Per SEC N-PORT · 2026-06-30 · by weight · factual
MDT on Stocklore
- Revenue by segment — segment weights verified from SEC filings, YoY changes, growth drivers and concentration
- Financials & earnings quality — 6 metrics (FCF conversion, ROIC, net debt, etc.) to gauge profit quality
- 13F institutional holdings — holdings and weight changes of major institutions (45-day delay)
- Sector-relative metrics — Valuation and growth compared with the Biotech & Health average
Peers · Biotech & Health
MDT FAQ
What is Medtronic plc (MDT)?
Medtronic. The world's largest medical-device company. It holds a broad product range in cardiac, neuro, spine, and diabetes fields.
What sector is Medtronic plc in?
Medtronic plc is classified under Biotech & Health. Pharma, biotech, and medical devices. Driven by trial-result events.
Where can I analyze Medtronic plc (MDT) stock?
On Stocklore you can see MDT's financials & earnings quality, 13F institutional holdings, and sector-relative metrics in one place. This page is for information and tools — not a buy/sell recommendation.
Data sources: SEC EDGAR (financials & filings), 13F (institutional holdings, as of quarter-end), market data. This page is for information and analysis tools — it does not recommend buying or selling any security. Investment decisions and responsibility are your own.